We’re In It For Patients
Our colleagues reflect on the patients and their families who inspire our work and keep us in it for good, for those we know personally, those we’ve connected with as part of our work and those we may never meet. Each and every story is a powerful reminder of why the work we do to bring new medicines to people with serious diseases is so important, no matter how long it takes or how difficult the journey.
Regeneron
September 24, 2026
Our colleagues reflect on the patients and their families who inspire our work and keep us in it for good. Watch Bari, Katy, Robert, Muriel, Umesh, Jennifer, Fady and Mack share their stories.
Bari explains why she’s in it for persistence: the kind required to move science forward across years, teams and countries.
Bari Kowal
Senior Vice President, Development Operations, Portfolio
Management & Biostatistics Data Management
Katy shares how patients like her mom fuel her to change what’s possible in medicine at Regeneron.
Katy Lastowski
Process Development Engineer III
Product, Analytical and Process Development
Rob shares how his own experience with cancer reinforces why he’s in it to amplify patient voices.
Robert Caruano
Senior Director, Patient Advocacy
Muriel describes why she’s in it for the families waiting on answers: because giving up is never an option.
Muriel O'Byrne, PhD
Senior Vice President, International Regulatory Affairs & Head,
European Business Office
Umesh tells why he’s in it to work together, because that’s the way we have the potential to change lives
Umesh Chaudhari, MD
Vice President, Global Program Head
Jennifer shares why she’s in it for the breakthroughs that change what is medically possible.
Jennifer Hamilton, PhD
Vice President, Precision Medicine
Fady explains why he’s in it to find answers to the next big questions.
Fady Tanios, PhD
Vice President, Medical Affairs
Mack tells how he’s in it to make the most of today’s digital and technology transformation to help improve human health.
Mack MacKenzie
Senior Vice President, Commercial and G&A Digital & Technology
Stay tuned as we release more stories from our colleagues about how and why they’re in it for good.
More Regeneron Stories